Jeffrey Nau

Insider Reports History

Entity
Individual
Location
202 Carnegie Center, Suite 106, Princeton, NJ
Signature
/s/ Brandon Fenn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Nau:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oyster Point Pharma, Inc. President and CEO, Director Common Stock 0 $11.20 Jan 3, 2023 By Spouse
Oyster Point Pharma, Inc. President and CEO, Director Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. President and CEO, Director Performance Stock Units 0 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. President and CEO, Director Stock Option (Right to Buy) 0 Jan 3, 2023 Direct

Insider Reports Filed by Jeffrey Nau

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OYST Oyster Point Pharma, Inc. Dec 1, 2022 1 -$100K 4/A Dec 6, 2022 President and CEO, Director
OYST Oyster Point Pharma, Inc. Jul 6, 2022 1 $0 4 Jul 8, 2022 President and CEO, Director
OYST Oyster Point Pharma, Inc. Jan 29, 2022 11 -$30.5K 4 Jan 4, 2023 President and CEO, Director
OYST Oyster Point Pharma, Inc. Jan 9, 2022 2 $0 4 Jan 11, 2022 President and CEO, Director
OYST Oyster Point Pharma, Inc. Oct 21, 2021 2 $51K 4 Oct 22, 2021 President and CEO, Director
OYST Oyster Point Pharma, Inc. Sep 1, 2021 2 $10.2K 4 Sep 1, 2021 President and CEO, Director